Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
334.25
+4.10 (+1.24%)
Streaming Delayed Price
Updated: 10:27 AM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
43
44
Next >
3 Top U.S. Stocks to Watch in January
January 06, 2023
Considering their potential, all three stocks look like good opportunities today.
Via
The Motley Fool
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
January 06, 2023
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2023
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Could the Dow Jones Keep Outperforming the Nasdaq Composite in 2023?
January 04, 2023
The Dow crushed the Nasdaq in 2022, but that's no guarantee of a lasting trend.
Via
The Motley Fool
If You Invested $100 In This Stock 20 Years Ago, You Would Have $500 Today
December 27, 2022
Via
Benzinga
10 Best Stock Traders In Congress In 2022 (Spoiler: Nancy Pelosi Isn't No. 1)
January 03, 2023
A new report was out about the performance of members of the U.S. Congress who bought and sold stocks and options in 2022. The report broke down unusual trading activity from members of Congress and...
Via
Benzinga
Meet the 2023 Dogs of the Dow
January 02, 2023
After a tumultuous year, this simple strategy that outperformed sagging markets might be just what you're looking for.
Via
The Motley Fool
10 Highest-Yielding Dow Jones Stocks Heading Into 2023
December 29, 2022
The stock market had a rough 2022 with many of the top indexes down double digits. Among the stock indexes that were down was the Dow Jones Industrial Average. With declining prices, dividend yields on...
Via
Benzinga
2 Unstoppable Dividend Growth Stocks to Buy in 2023 and Beyond
December 29, 2022
Nothing is more reassuring to an income investor than a boost to the dividend.
Via
The Motley Fool
The Battles Brewing That Could Stoke Already Red-Hot Eli Lilly Stock
December 28, 2022
Investors are closely watching two key spaces that could spark Lilly stock.
Via
Investor's Business Daily
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
December 24, 2022
For these companies' shareholders, it may be tempting to take profits right now. But both stocks can keep growing for a while.
Via
The Motley Fool
2 No-Brainer Biotech Stocks to Buy Right Now
December 22, 2022
Vertex Therapeutics and Amgen have the building blocks for long-term success.
Via
The Motley Fool
Alphabet To $115? Here Are 10 Other Price Target Changes For Thursday
December 22, 2022
Stifel raised argenx SE (NASDAQ: ARGX) price target from $471 to $478. Stifel analyst Alex Thompson maintained a Buy rating on the stock. argenx shares rose 1.1% to $387.07 in pre-market trading.
Via
Benzinga
Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks
December 21, 2022
Even if interest rates go up, you likely won't need to worry about these stocks.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 16, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
December 16, 2022
Moderna spiked on a cancer vaccine while Tesla continued to dive.
Via
Investor's Business Daily
2 Best Biotech Stocks to Buy Right Now
December 16, 2022
Demand for medicines and vaccines has nowhere to go but up over the long run.
Via
The Motley Fool
20 Dividend Growth Stocks For Faster Growth And Profit
December 15, 2022
The equal weight growth model was willing to accept faster-growing companies with lower current dividend yields, but faster-growing dividends.
Via
Talk Markets
The Best ETF For Dividend Yield And Dividend Growth
December 15, 2022
This ETF checks off all the boxes in terms of performance, dividend growth, and solid yield.
Via
The Motley Fool
Finding 20 Dividend Growth Stocks In A Bad Market
December 14, 2022
Starting in 2012, it became more and more difficult for prudent dividend growth stock investors looking for income. The stock market was trading at excessive valuations, and interest rates were at...
Via
Talk Markets
Harpoon Therapeutics Remains Volatile After Promising News
December 14, 2022
Harpoon Therapeutics offers an example of biotech's volatility. The stock advanced as much as 191% intraday Monday before settling down to a gain of 22.61%.
Via
MarketBeat
The Bullish Call Eli Lilly Made For Its Next-Gen Obesity Drug, A Rival To Novo, Amgen
December 13, 2022
All eyes are on tirzepatide, but its next-generation weight-loss shot could be even better.
Via
Investor's Business Daily
Pinterest To Rally Around 23%? Here Are 10 Other Price Target Changes For Tuesday
December 13, 2022
Via
Benzinga
Cramers Says These 3 Big Deals Aided Monday's Market Rally: 'When Companies Start Buying Each Other At A Big Premium...'
December 13, 2022
Prominent market commentator Jim Cramer said three corporate deals announced on Monday aided the rally seen at the beginning of the week,
Via
Benzinga
Nasdaq, S&P 500 Futures Soar Amid Optimistic Expectations Concerning Nov. Inflation: Oracle, Tesla, Pinterest Among Early Movers
December 13, 2022
The index futures point to a modestly higher opening for the market on Tuesday, although the November consumer price inflation due ahead of the open could sway sentiment either way depending on how the...
Via
Benzinga
Tesla, Apple, Rivian, Horizon, Paypal: Why These 5 Stocks Are Drawing Investors' Attention Today
December 12, 2022
Major Wall Street indices closed over 1% higher on Monday after last week’s subdued performance.
Via
Benzinga
Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues
December 12, 2022
FDA action on its KRAS-blocking drug could help recently downtrodden Mirati.
Via
Investor's Business Daily
Here's Where Amgen's Loan To Acquire Horizon Therapeutics For $28B Ranks Among M&A Deals In 2022
December 12, 2022
Amgen Inc's (NASDAQ: AMGN) deal to acquire Horizon Therapeutics (NASDAQ: HZNP) requires a sizable loan that ranks among the biggest debt commitments for
Via
Benzinga
Why Horizon Therapeutics Stock Is Soaring Today
December 12, 2022
Amgen's planned acquisition of Horizon could close in the first half of next year.
Via
The Motley Fool
What's Going On With Amgen Stock Today?
December 12, 2022
Amgen Inc (NASDAQ: AMGN) shares are trading lower Monday after the company announced it will acquire Horizon Therapeutics (NASDAQ: HZNP)
Via
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
43
44
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.